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In high glucose protein kinase C-f activation is required for
mesangial cell generation of reactive oxygen species.
Background. We postulated that in mesangial cells exposed
to high glucose, protein kinase C-f (PKC-f ) is necessary for the
generation of reactive oxygen species (ROS) by nicotinamide
adenine dinucleotide phosphate (NADPH) oxidase and that the
requirement of PKC-f for filamentous (F)-actin disassembly
may involve ROS. To identify signaling mechanisms relevant to
PKC-f activation and ROS generation, including phosphoinosi-
tide 3 kinase (PI3 kinase), we examined mesangial cell stimula-
tion with platelet-derived growth factor (PDGF).
Methods. In primary rat mesangial cells cultured in
5.6 mmol/L or 30 mmol/L D-glucose, PKC-f expression was
identified with immunoblotting and activity was analyzed in cell
membrane immunoprecipitates and by confocal immunofluo-
rescence imaging. ROS generation was measured by dichlo-
rofluorescein fluorescence using confocal microscopy and was
inhibited by transfection of antisense against NADPH subunits
p22phox or p47phox or with Tempol. F-actin disassembly was
observed by dual-channel confocal fluorescence imaging. PI3
kinase activity was detected by immunoblotting of phosphory-
lated Akt.
Results. In high glucose, generation of NADPH oxidase–
dependent ROS was dependent on PKC-f . Conversely, sus-
tained PKC-f activity was dependent on ROS generation,
suggesting a positive feedback. PKC-f–dependent F-actin dis-
assembly in high glucose required ROS generation. PDGF stim-
ulated NADPH oxidase generation of ROS through a PKC-f
mechanism that was independent of Akt phosphorylation and
remained unchanged in high glucose.
Conclusion. In high glucose, mesangial cell PKC-f is required
for ROS generation from NADPH oxidase similar to PDGF
stimulation of PKC-f–dependent ROS generation through a
pathway independent of PI3 kinase. F-actin disassembly in high
glucose also requires ROS. A positive feedback loop occurs
between ROS and the activation of PKC-f in high glucose.
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Diabetic nephropathy is the leading cause of end-stage
renal failure in North America [1]. High glucose trans-
forms the glomerular mesangial cell into a myofibroblast
phenotype that synthesizes excessive collagen IV con-
tributing to glomerulosclerosis [2]. The effects of high
glucose on mesangial cells include altered signaling in
response to growth factors, both enhanced [e.g., protein
kinase C (PKC)–dependent pathways [3]] and reduced
(e.g., Ca2+ signaling [4]). The enhanced expression of
growth factors and their receptors, including transform-
ing growth factor-b1 (TGF-b1) [5] and platelet-derived
growth factor (PDGF) [6], in response to high glucose,
may contribute to the progression of the myofibroblast
phenotype through autocoid signaling mechanisms. The
generation of reactive oxygen species (ROS) by mesan-
gial cells is now recognized as one of the earliest responses
to high glucose [7] and appears to be dependent on PKC
[4]. The cellular mechanisms that integrate these signal-
ing events are incompletely understood.
In mesangial cells exposed to high glucose, the activity
of individual PKC isozymes is detected [8]. Basal activ-
ity of PKC may contribute to the maintenance of nor-
mal mesangial cell phenotype, whereas enhanced PKC
activity may be required to maintain a more dedifferenti-
ated state. High glucose–induced disassembly of mesan-
gial cell filamentous (F)-actin both in primary culture
and in glomeruli isolated from diabetic rats [9] is PKC-
dependent [10]. We have previously demonstrated that
a specific peptide inhibitor of PKC-f prevents F-actin
disassembly and loss of normal contractility to vasopres-
sor peptides in high glucose [11]. Reduced mesangial cell
Ca2+ signaling in response to endothelin-1 is dependent
on the interaction between diacylglycerol-sensitive PKC
isozymes and nicotinamide adenine dinucleotide phos-
phate (NADPH) oxidase ROS production [4]. The in-
volvement of high glucose–mediated activation of PKC
in NADPH oxidase generation of ROS has been de-
scribed recently [12, 13], although the role of specific
PKC isozymes has not been elucidated. NADPH oxi-
dase is a multicomponent enzyme complex that converts
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molecular oxygen to superoxide anion. It is composed
of the heterodimeric membrane–associated components
gp91phox and p22phox, the cytosolic components p47phox
and p67phox, and the small guanosine triphosphatases
(GTPases) Rac1 or Rac2 [14]. NADPH oxidase is known
to be expressed in mesangial cells [15, 16] and appears to
be a main source of ROS in this cell type [4, 12].
PDGF is a potent mitogen that stimulates extracel-
lular matrix accumulation in mesangial cells [17]. The
expression of both PDGF and PDGF-BB receptors is
up-regulated by mesangial cells exposed to high glucose
[6, 18]. In high glucose, mesangial cell signaling through
the p38 pathway in response to PDGF is amplified [19]. A
regulatory role played by PKC in high glucose–enhanced
PDGF stimulation has been identified in the retina of
diabetic rats and in cultured retinal capillary pericytes
[20]. PDGF signal transduction stimulates many path-
ways, including the phosphoinositide 3 kinase (PI3 ki-
nase) pathway [21], which could lead to PKC-f activation
[22] through activation of phosphoinositide-dependent
kinase-1 (PDK-1) [23, 24]. In the streptozotocin (STZ)-
induced diabetic rat model, increased PI3 kinase activity
is reported in liver and skeletal muscle [25].
In this study, we examined the mechanisms whereby
PKC-f plays a key role in transforming mesangial cell
function in response to high glucose. We postulated that
in high glucose, PKC-f is necessary for the generation
of ROS by NADPH oxidase and that the requirement
of PKC-f for F-actin disassembly may involve ROS.
Furthermore, we hypothesized that in mesangial cells,
PDGF simulates PKC-f and consequent ROS genera-
tion, and that this response may be amplified in high glu-
cose through a mechanism that involves the PI3 kinase
pathway.
The experiments were performed in primary cultured
rat mesangial cells comparing 5.6 mmol/L to 30 mmol/L
D-glucose, using 24.4 mmol/L L-glucose + 5.6 mmol/L
D-glucose as an osmotic control. PKC-f expression was
identified with immunoblotting and activity was ana-
lyzed in cell membrane immunoprecipitates as well as
by confocal immunofluorescence imaging. ROS gen-
eration was measured by dichlorofluorescein (DCF)
fluorescence imaging using confocal microscopy and
with an assay measuring the release of superoxide an-
ion by intact cells with 2-methyl-6-(4-methoxyphenyl)-
3,7-dihydroimidazol [1,2-a]pyrazin-3-one, hydrochloride
(MCLA). F-actin disassembly was observed by dual-
channel confocal fluorescence imaging whereby F- and
globular (g)-actin were imaged simultaneously in the
same cells. Activity of the PI3 kinase pathway was de-
tected by immunoblotting of phosphorylated Akt. Our
findings support interaction between mesangial cell PKC-
f activation and sustained ROS generation, which is re-
quired for sustained mesangial cell PKC-f activation and
F-actin disassembly in high glucose. Similar to high glu-
cose, PDGF simulates NADPH oxidase generation of
ROS and PKC-f activation independent of the PI3 ki-
nase pathway.
METHODS
Materials
Dulbecco’s modified Eagle medium (DMEM) and
Lipofectamine 2000 were purchased from Invitrogen
Corporation (Burlington, ON, Canada). Fetal bovine
serum (FBS) was purchased from Winsent Inc. (St.
Bruno, QC, Canada). Trypsin was purchased from Gibco
BRL Life Technologies (Burlington, ON, Canada).
5-(and-6)-chloromethyl-2′,7′-dichlorodihydrofluorescein
diacetate (CM-H2DCFDA), rhodamine phalloidin, flu-
orescein isothiocyanate–conjugated deoxyribonuclease
I (FITC-DNase-1), and MCLA were purchased from
Molecular Probes Inc. (Eugene, OR, USA). PDGF was
purchased from Boehringer Mannheim (Mannheim,
Germany). nPKC-f (C-20) antibody (noncrossreactive
with other PKC isoforms) utilized for immunoprecip-
itation and protein G Plus Agarose were purchased
from Santa Cruz Biotechnology, Inc. (Santa Cruz,
CA, USA). PKC-e pseudosubstrate was purchased
from Biomol Research Laboratories Inc. (Plymouth
Meeting, PA, USA). Cell-permeant myristoylated
peptide (N-myristoyl-SIYRRGARRWRKL) [26] that
inhibits PKC-f activity [PKC-f peptide inhibitor (ZI)]
was synthesized by the Advanced Protein Technology
Center, Peptide Synthesis Facility, The Hospital for Sick
Children (Toronto, ON, Canada). Antisense oligonu-
cleotides against the NADPH oxidase subunits p22phox
and p47phox were synthesized by The Center for Applied
Genomics, DNA Synthesis Facility, Hospital for Sick
Children (Toronto, ON, Canada). Antiphospho-Akt
(Ser473) and anti-Akt antibodies were purchased
from Cell Signaling Technology (Beverly, MA, USA).
Anti-PKC-f antibody (corresponding to the C terminal
variable (V5) region of rat PKC-f ) utilized for Western
immunoblotting, diphenyleneiodonium chloride (DPI),
diethyl maleate (DEM), wortmannin, 5(6)-carboxy-
2′,7′-dichlorofluorescein diacetateN-succinimidyl ester
(C-DCFDA), xanthine, xanthine oxidase and 4-hydroxy-
TEMPO (Tempol) were purchased from Sigma-Aldrich
(St. Louis, MO, USA). FITC-conjugated AffiniPure goat
antirabbit IgG antibody was purchased from Jackson
Immuno Research Laboratories, Inc. (West Grove, PA,
USA). Goat antirabbit IgG horseradish peroxidase
conjugate was purchased from Bio-Rad Laboratories
(Hercules, CA, USA). Anti-PKC-k monoclonal antibody
was purchased from BD Biosciences (San Jose, CA,
USA).
Mesangial cell culture
Primary rat mesangial cells were isolated from male
Sprague-Dawley rat kidney glomeruli (Charles River,
QC, Canada) through seiving of the kidney cortex and
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characterized as previously described [27]. Cells were cul-
tured in DMEM containing 5.6 mmol/L D-glucose and
20% FBS to near-confluence and growth-arrested in ei-
ther 5.6 mmol/L D-glucose or 30 mmol/L D-glucose and
0.5% FBS for 48 hours. Mesangial cells of passages 8 to
15 were used for all studies.
Transfection of p22phox and p47phox antisense
oligonucleotides
Mesangial cell NADPH oxidase activity was inhib-
ited by transfecting cells with phosphothioate-modified
antisense oligonucleotides against the NADPH oxidase
subunits p22phox or p47phox using the cationic lipid trans-
fection reagent, Lipofectamine 2000, in accordance with
the manufacturer’s instructions. Scrambled sequences for
both subunits were used as negative controls. The p22phox
antisense sequence was 5′-GAT CTG CCC CAT GGT
GAG GAC C-3′ [28]. The p22phox scrambled sequence
was 5′-TAG GCA TAG CCG CTC CGC TGG A-3′. The
p47phox antisense sequence was 5′-GGT GTC CCC CAT
GGC TGG GCA G-3′ (GenBank AY029167, nt 5-26).
The p47phox scrambled sequence was 5′ TGA GGC TCC
GTC CGC TGG AGC G-3′.
DCF fluorescence confocal imaging
Mesangial cells were cultured on glass coverslips and
incubated in the dark with phosphate buffer solution con-
taining 10 lmol/L CM-H2DCFDA for 1 hour or 1 lmol/L
C-DCFDA for 30 minutes at 37◦C. CM-H2DCFDA
and C-DCFDA are nonpolar, membrane-permeable
compounds that are converted to the polar, membrane-
impermeable compound, 2′7′-dichlorofluorescein by in-
tracellular esterases. This is converted to the fluorescent
compound, DCF following exposure to intracellular
H2O2. Cells were pretreated with 1 mmol/L DEM for
30 minutess in order to inhibit ROS scavengers and
cause accumulation of ROS as a positive control. Pre-
treatment with 1 lmol/L DPI for 1 hour was used to in-
hibit NADPH oxidase. Intracellular ROS production, as
determined by fluorescence intensity, was observed by
confocal laser scanning microscopy (LSM 410) (Zeiss,
Du¨sseldorf, Germany) using an excitation wavelength of
488 nm and an emission wavelength of 513 nm. Fluores-
cence intensity per cell was analyzed using a Dell Di-
mension 8100 PC (Dell Computer Coroporation, North
York, ON, Canada) and Scion Image for Windows Beta
4.0.2 analysis software (Scion Corporation, Frederick,
MD, USA).
MCLA fluorescence assay
MCLA, a sensitive analogue of lucigenin, was used to
measure superoxide anion released by the cell into the
culture medium [29]. NADPH, a necessary substrate for
NADPH oxidase, was added to optimize the detection of
NADPH oxidase-released superoxide anion. Cells were
cultured, trypsinized and transferred into 96-well sterile
microplates. They were then incubated in a buffer so-
lution containing 136 mmol/L NaCl, 5.4 mmol/L KCl,
0.83 mmol/L MgSO4, 0.45 mmol/L KH2PO4, 1.3 mmol/L
CaCl2 • 2 H2O, 0.13 mmol/L Na2HPO4 • 7 H2O,
20 mmol/L Hepes, 5 mmol/L diethyldithiocarbamate
(DETC), 0.1 mol/L D-glucose, 0.25% bovine serum albu-
min (BSA), 1 lmol/L MCLA, and 10 mmol/L NADPH
at 37◦C while being measured for 20 seconds in a mi-
croplate luminometer (LB 96V) (Berthold Technologies,
Oak Ridge, TN, USA). The xanthine/xanthine oxidase
reaction is widely known as a source of superoxide an-
ion and H2O2 [30]. Thus, wells containing 0.4 lmol/L
xanthine plus 0.002 U xanthine oxidiase were used as
positive controls. Luminescence measurements were ob-
tained by subtracting the buffer negative control mea-
surement from the luminescence signal and normalized
to cell number or to cellular protein content per well.
Western immunoblotting of phospho-Akt, Akt, PKC-f,
and PKC-k
Total cell lysates were obtained by lysing cells using 2×
sodium dodecyl sulfate (SDS) sample buffer (0.13 mol/L
Tris base, 20% glycerol, and 4% SDS). Protein concentra-
tion was determined using a modified Lowry microassay
(Bio-Rad) and samples of equal protein amount (10 lg)
were separated using 10% SDS-polyacrylamide gel elec-
trophoresis (PAGE) at room temperature for 11/2 hours at
120 V. Following an overnight transfer at 4◦C and 32 V, the
polyvinylidine difluoride (PVDF) membranes (Bio-Rad)
were incubated at room temperature for 1 hour in a Tris
buffer containing 5% nonfat milk and 0.05% Tween-20
to prevent nonspecific binding. Equal protein loading was
analyzed by Ponceau S detection. Membranes were then
probed with the appropriate primary antibody for 1 hour
and subsequently, a horseradish peroxidase–conjugated
affinity-purified goat antirabbit IgG antibody for 20 min-
utes. The secondary antibody was detected by chemilu-
minescence (Amersham Biosciences, Buckinghamshire,
England), and blots were developed on Kodak X-Omat
AR film (Eastman Kodak, Rochester, NY, USA). PI3 ki-
nase activity was inhibited by pretreatment of cells with
1 lmol/L wortmannin for 1 hour. Cells were pretreated
with 50 ng/mL PDGF for 10 minutes or 1 mmol/L DEM
for 30 minutes in order to assess the respective roles of
growth factors and ROS in PI3 kinase activity. Densitom-
etry was performed using a Dell Dimension 8100 PC and
Scion Image for Windows Beta 4.0.2 analysis software.
PKC-f activity assay
PKC-f activity was directly measured in PKC-f
immunoprecipitated membrane fractions through 33P-
phosphorylation of PKC-f crossreactive Ser159-PKC-e
(ERMRPRKRQGSVRRRV), a synthetic peptide corre-
sponding to amino acids 149–164 of the PKC-e pseudo-
substrate motif, substituting Ser for Ala159 [31, 32]. To
Kwan et al: Activation of mesangial cell protein kinase C-f in high glucose 2529
Pi
xe
l i
nt
en
si
ty
/c
el
l
200
180
160
140
120
100
80
60
40
20
0
Control
DPI
DEM
NG
3h
HG
48h
HG
48h 3h 48h
5.6 mmol/L
D-glu
5.6 mmol/L D-glu
+
24.4 mmol/L L-glu
Control DPI DEM
NG 3h HG 48h HG
*
*
*
**
**
**
*
***
***
A
B
Fig. 1. Role of nicotinamide adenine dinucleotide phosphate (NADPH) oxidase in high glucose–enhanced reactive oxygen species (ROS) genera-
tion as detected using dichlorofluorescein (DCF) confocal imaging. (A) Cells were growth arrested in 5.6 mmol/L normal glucose (NG) or 30 mmol/L
D-glucose [high glucose (HG)] for 3 hours or 48 hours. To determine the role of NADPH oxidase in ROS production, cells were pretreated with
1 lmol/L diphenylenechloride iodonium (DPI) for 1 hour or 1 mmol/L diethyl maleate (DEM) for 30 minutes. Fluorescence pixel intensity per cell
was analyzed from 60 cells obtained from three separate experiments. ∗P < 0.001 vs. normal glucose control; ∗∗P < 0.001 vs. 3-hour high glucose
control; ∗∗∗P < 0.001 vs. 48-hour high glucose control. (B) The osmotic effect on ROS generation of L-glucose was compared to D-glucose. Images
are representative of three separate experiments (magnification bar 25 lm).
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Fig. 2. Effect of p22phox and p47phox antisense on dichlorofluorescein (DCF)-detected reactive oxygen species (ROS) production. Antisense
oligonucleotides against the nicotinamide adenine dinucleotide phosphate (NADPH) oxidase subunits p22phox and p47phox were transfected into
growth-arrested cells in 5.6 mmol/L normal glucose (NG) or 30 mmol/L D-glucose [high glucose (HG)] for 48 hours. Scrambled (Scr) sequences of
both subunits were also transfected to confirm NADPH oxidase specificity. Images are representative of three separate experiments (magnification
bar 25 lm).
obtain membrane fractions, cells were lysed in ice-cold ly-
sis buffer containing 25 mmol/L Hepes, 150 mmol/L NaCl,
1 mmol/L ethyleneglycol tetraacetate (EGTA), 2 mmol/L
ethylenediaminetetraacetic acid (EDTA), 10 mmol/L
NaF, 50 mmol/L b-glycerophosphate, 1 mmol/L sodium
orthovanadate, 1% Triton-X, 100 nmol/L okadaic acid,
0.4 mmol/L phenylmethylsulfonyl fluoride (PMSF),
20 lg/mL aprotinin, 20 lg/mL leupeptin, and 10 mmol/L
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Fig. 3. Effect of high glucose (HG) on 2-methyl-6-(4-methoxyphenyl)-
3,7-dihydroimidazol [1,2-a]pyrazin-3-one, hydrochloride (MCLA)–
detected extracellular reactive oxygen species (ROS) production. Cells
were growth-arrested in 5.6 mmol/L normal glucose (NG) or 30 mmol/L
D-glucose (HG) for 48 hours and extracellular ROS generation was
evaluated using a MCLA fluorescence assay. ∗P < 0.005 vs. normal glu-
cose normalized for cell count (N = 7); ∗∗P < 0.0001 vs. normal glucose
normalized for cellular protein content (N = 6).
benzamidine. The lysate was then passed through a 26-
gauge needle and centrifuged at 50,000g for 1 hour at 4◦C
(TL-100) (Beckman Instruments Canada, Mississauga,
ON, Canada). The pellet was collected, resuspended in
lysis buffer plus 1% Triton X-100, and centrifuged at
50,000g for an additional 1 hour. The supernatant was
collected as the membrane fraction. Each membrane
sample was immunoprecipitated with anti-PKC-f anti-
body and isolated using protein G Plus Agarose. In each
experimental group, a control sample was also immu-
precipitated with nonspecific rabbit IgG. The isolated
PKC-f or control samples were incubated with a reac-
tion buffer containing 40 lmol/L PKC-e-pseudosubstrate
peptide, 3000 Ci/mmol/L 33P-adenosine triphosphate
(ATP), 40 lmol/L ATP, 0.2 mmol/L PMSF, 20 lg/mL
aprotinin, 20 lg/mL leupeptin, 100 nmol/L okadaic acid,
and 20 lL phosphatidylserine for 8 minutes at 30◦C
[32]. The reaction was terminated by quenching sam-
ples with a solution containing 0.1 mmol/L ATP and
100 mmol/L EDTA. Samples were then spotted on p81
phosphocellulose paper (Fisher Scientific, Ottawa, ON,
Canada), after which kinase activity was measured via
33P-pseudosubstrate labeling using liquid scintillation
counting (LS 6500) (Beckman Instruments Inc., Fuller-
ton, CA, USA). The generation of ROS was inhibited by
pretreating cells with 100 nmol/L Tempol, a superoxide
dismutase mimetic, for 48 hours.
Immunofluorescence confocal imaging of PKC-f
Cells were cultured on glass coverslips and follow-
ing experimental intervention were fixed using 3.7%
formaldehyde at room temperature for 10 minutes
and permeabilized with 100% methanol at −20◦C for
10 minutes. Following cell treatment with 1% goat serum
containing 0.1% BSA at room temperature for 1 hour
to prevent nonspecific binding, cells were incubated with
anti-PKC-f monoclonal antibody at 37◦C for 1 hour. The
primary antibody was detected using FITC-conjugated
goat antirabbit IgG at 37◦C for 1 hour. PKC-f activity was
evaluated indirectly by changes in immunofluorescence
observed by confocal imaging using an excitation wave-
length of 488 nm and an emission wavelength 520 nm.
Fluorescence intensity per cell was analyzed using a Dell
Dimension 8100 PC and Scion Image for Windows Beta
4.0.2 analysis software.
Dual-channel confocal fluorescence microscopy
of F-actin and g-actin
Cells were cultured on glass coverslips and follow-
ing experimental intervention were fixed using 3.7%
formaldehyde at room temperature for 10 minutes and
permeabilized with 0.1% Triton X-100 at room tempera-
ture for 10 minutes. Cells were incubated simultaneously
with rhodamine phalloidin to detect F-actin and FITC-
DNase-1 to detect g-actin for 30 minutes in the dark at
room temperature. Dual-channel confocal image analysis
was used to assess F-actin disassembly. Excitation wave-
lengths of 568 nm and 488 nm and emission wavelengths
of 573 nm and 517 nm were employed for rhodamine
phalloidin and FITC-DNase-1, respectively. F-actin and
g-actin fluorescence intensity was measured in the same
cell.
Statistical analysis
All results are presented as mean ± SEM. Statisti-
cal analyses were performed using InStat 2.01 (Graph
Pad, Sacramento, CA, USA). Unpaired Student t tests
were used to compare the means of two groups. One-
way analysis of variance (ANOVA) was used to compare
the means of three groups or more, after which Tukey-
Kramer multiple comparisons tests were used for post
test analysis.
RESULTS
Role of NADPH oxidase in high glucose–enhanced ROS
generation
In high glucose compared to normal glucose, intracel-
lular ROS, as measured by confocal fluorescence imag-
ing in DCF-loaded mesangial cells, increased by 2.1- and
2.7-fold at 3 hours and 48 hours, respectively. The in-
crease in ROS production seen in high glucose was in-
hibited by DPI, an NADPH oxidase inhibitor [33], but
enhanced by DEM, an inhibitor of ROS scavengers [34]
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Fig. 4. Role of high glucose and reactive oxygen species (ROS) on protein kinase C-f (PKC-f) expression and activity. (A) Western immunoblotting
of total cell lysates growth-arrested in 5.6 mmol/L normal glucose (NG) or 30 mmol/L D-glucose [high glucose (HG)] for 48 hours. Images are
representative of three separate experiments. Comparison of PKC-f and -k expression using rat brain total cell lysate as a positive control (+)
for PKC-k. (B) Membrane-associated immunoprecipitated kinase activity of PKC-f of cells growth-arrested in normal glucose or high glucose for
48 hours. The specificity of the assay was confirmed by cell pretreatment with PKC-f peptide inhibitor (ZI). The effect of ROS on PKC-f activity
was assessed by pretreatment with 100 nmol/L Tempol. Bars are representative of four separate experiments. ∗P < 0.001 vs. normal glucose control;
∗∗P < 0.001 vs. 48-hour high glucose control. (C and D) Confocal immunofluorescence PKC-f imaging of cells growth-arrested in normal glucose
or high glucose for 48 hours. PKC-f activity was inhibited using cell pretreatment with ZI. Cells were pretreated with 100 nmol/L Tempol to assess
the role of ROS. Fluorescence pixel intensity per cell was analyzed from 60 cells obtained from three separate experiments. ∗P < 0.001 vs. normal
glucose control; ∗∗P < 0.001 vs. 48-hour high glucose control. (E) Osmotic effects on PKC-f confocal immunofluorescence imaging of L-glucose
compared to D-glucose. Images are representative of three separate experiments (magnification bar 25 lm).
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in 5.6 mmol/L normal glucose (NG) or
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determine the role of PKC-f in ROS pro-
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peptide inhibitor (ZI). Fluorescence pixel in-
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0.001 vs. normal glucose control; ∗∗P < 0.001
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(Fig. 1A). By comparison, ROS production remained un-
changed following exposure to high L-glucose for 3 hours
and 48 hours (Fig. 1B).
The increase in ROS production seen in high glucose
was prevented using antisense oligonucleotides against
the NADPH oxidase subunits p22phox or p47phox. Scram-
bled sequences of both subunits were used as negative
controls to ensure the specificity of the antisense oligonu-
cleotides in the inhibition of NADPH oxidase (Fig. 2).
Since NADPH oxidase has been implicated as the
primary source of superoxide anion in mesangial cells,
MCLA chemiluminescence was employed to assess ex-
tracellular superoxide anion released into the medium.
In 48 hours high glucose relative to normal glucose
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Fig. 6. Effect of platelet-derived growth factor (PDGF) on protein kinase C-f (PKC-f) activity. (A) Membrane-associated immunoprecipitated
kinase activity of PKC-f of cells growth-arrested in 5.6 mmol/L normal glucose (NG) or 30 mmol/L D-glucose [high glucose (HG)] for 48 hours. Bars
are representative of mean value of four separate experiments. (B) Confocal immunofluorescence PKC-f imaging of cells growth-arrested in normal
glucose or high glucose for 48 hours. Fluorescence pixel intensity per cell was analyzed from 60 cells obtained from three separate experiments.
PKC-f was inhibited using PKC-f peptide inhibitor (ZI). Cells were stimulated with 50 ng/mL PDGF for 10 minutes. Images are representative of
three separate experiments (magnification bar 25 lm). ∗P < 0.001 vs. normal glucose control; ∗∗P < 0.001 vs. normal glucose + PDGF; ∗∗∗P < 0.001
vs. 48-hour high glucose + PDGF.
conditions, MCLA-detected superoxide anion release
normalized to cellular protein or cell count increased
by twofold and 2.1-fold, respectively (Fig. 3). The xan-
thine/xanthine oxidase reaction produced a luminescence
signal 6.2-fold over the normal glucose control, demon-
strating the specificity of the superoxide anion assay.
PKC-f activity and ROS generation in high glucose
Expression of PKC-f , as detected by Western im-
munoblotting of total cell lysates, remained unchanged
following a 48-hour exposure to high glucose (Fig. 4A).
PKC-f activity was inhibited using ZI, a cell-permeant
myristoylated peptide corresponding to amino acids 113–
125 of the PKC-f regulatory subunit (N-myristoyl-SIYR
RGARRWRKL) [35]. This sequence is homologous be-
tween all atypical PKC isoforms [36] and the pep-
tide suppresses PKC activity through interaction with
the regulatory domain [37]. Western immunoblotting of
PKC-f and -k using total cell lysates (30 lg samples)
revealed that the mesangial cells used in this study ex-
pressed predominantly PKC-f and very small amounts
of PKC-k in both normal and high glucose (Fig. 4A).
The membrane-associated immunoprecipitated kinase
activity of PKC-f increased by twofold and 2.1-fold above
activity in normal glucose following exposure to high glu-
cose for 3 hours (data not shown) and 48 hours, respec-
tively. The PKC-f activity measured in normal or high
glucose was normalized following cell pretreatment with
ZI (Fig. 4B).
In order to assess the effects of ROS on PKC-f
kinase activity, mesangial cells were pretreated with
the membrane-permeable, metal-independent superox-
ide dismustase mimetic, Tempol [38]. Cell pretreatment
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Fig. 7. Effect of platelet-derived growth fac-
tor (PDGF) on reactive oxygen species (ROS)
generation. Representative confocal images
of dichlorofluorescein (DCF)-loaded mesan-
gial cells growth-arrested in 5.6 mmol/L nor-
mal glucose (NG) or 30 mmol/L D-glucose
[high glucose (HG)] for 48 hours. (A) Cells
were pretreated with PKC-f peptide inhibitor
(ZI) to determine the role of PKC-f . ∗P <
0.001 vs. normal glucose control; ∗∗P < 0.001
vs. normal glucose + PDGF; ∗∗∗P < 0.001
vs. 48-hour high glucose + PDGF. (B) Cells
were transfected with antisense oligonu-
cleotides against the nicotinamide adenine
dinucleotide phosphate (NADPH) oxidase
subunit p22phox. A scrambled (Scr) sequence
was transfected to confirm NADPH oxidase-
specificity. ∗P < 0.001 vs. normal glucose con-
trol; ∗∗P < 0.001 vs. normal glucose + PDGF
+ p22 Scr; ∗∗∗P < 0.001 vs. 48-hour high
glucose + PDGF + p22 Scr. Fluorescence
pixel intensity per cell was analyzed from
60 cells obtained from three separate exper-
iments. Cells were stimulated with 50 ng/mL
PDGF for 10 minutes. Images are represen-
tative of three separate experiments (magni-
fication bar 25 lm).
with Tempol attenuated both the basal PKC-f kinase
activity in normal glucose, as well as the elevated
kinase activity resulting from high glucose exposure
(Fig. 4B).
Confocal immunofluorescence imaging of PKC-f was
used as an additional measure of PKC-f activity. Con-
focal imaging identified increased immunofluorescence
of PKC-f following a 48-hour exposure to high glucose
which was inhibited with ZI. This activation pattern was
also prevented by cell pretreatment with Tempol (Fig. 4C
and D).
To determine whether the effects of high glucose were
due to increased osmolality, PKC-f immunoflurescence
was compared in high D- and L-glucose (Fig. 4E). High
L-glucose had no effect on PKC-f immunofluorescence.
Mesangial cell pretreatment with ZI prevented ROS
generation at 3-hour and 48-hour exposures to high glu-
cose (Fig. 5).
PDGF stimulation of ROS production and the role of
PKC-f
Immunoprecipitated kinase activity of PKC-f was en-
hanced during stimulation with PDGF in normal glucose.
Stimulation with PDGF in high glucose was not signifi-
cantly different (Fig. 6A). Stimulation with PDGF in nor-
mal glucose and high glucose conditions also resulted in
enhanced PKC-f immunofluorescence analyzed by con-
focal imaging. This pattern was confirmed to represent
acute activation of PKC-f as it was prevented with ZI.
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Fig. 7. (continued)
Stimulation for 10 minutes with PDGF resulted in in-
creased DCF-detected ROS generation in normal glu-
cose and in 48-hour high glucose that was attenuated by
pretreatment with ZI (Fig. 7A). Moreover, this increase
in ROS generation resulting from PDGF stimulation was
also inhibited using antisense oligonucleotides against
the NADPH oxidase subunit p22phox in normal and high
glucose. A scrambled version of the oligonucleotide se-
quence was used as a negative control (Fig. 7B).
Role of PI3 kinase pathway
The phosphorylation of Akt, a direct substrate of
PI3 kinase, was used as an indirect measure of PI3
kinase activity. Western immunoblots of total- and
phosphorylated-Akt from the same samples were com-
pared. Phosphorylation of Akt remained unchanged fol-
lowing exposure to high glucose for 48 hours. On the
other hand, stimulation with PDGF in normal glucose
resulted in an increase in Akt phosphorylation. High glu-
cose exposure did not enhance Akt phosphorylation re-
sulting from PDGF stimulation (Fig. 8A). The effect of
ROS on the activation of the PI3 kinase pathway was
tested through incubation with DEM in normal glucose,
in which phosphorylation of Akt remained unaffected
relative to the normal glucose control. Wortmannin, a
specific inhibitor of PI3 kinase, eliminated the phospho-
rylation of Akt (Fig. 8B).
Wortmannin did not affect ROS generation in normal
and high glucose. In addition, Wortmannin did not inhibit
mesangial cell ROS generation during PDGF stimulation
in either normal or high glucose (Fig. 9).
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Fig. 8. Role of phosphoinositide 3 kinase (PI3 kinase) pathway as measured by Akt phosphorylation. Comparison of Western immunoblots of total
and phosphorylated Akt. Total cell lysates of cells growth-arrested in 5.6 mmol/L normal glucose (NG) or 30 mmol/L D-glucose [high glucose (HG)]
for 48 hours were obtained. Cells were stimulated with 50 ng/mL platelet-derived growth factor (PDGF) for 10 minutes (A) or were pretreated with
1 mmol/Ldiethyl maleate (DEM) for 30 minutes (B). Cells were treated with 1 lmol/L Wortmannin for 1 hour to inhibit PI3 kinase. Bars represent
mean values of four separate experiments. Images are representative blots. ∗P < 0.05 vs. normal glucose control.
High glucose–induced F-actin disassembly
Dual-channel fluorescence confocal microscopy of
rhodamine phalloidin-labeled F-actin and FITC-DNase-
1–labeled g-actin was employed to assess F-actin disas-
sembly. A 48-hour exposure to high glucose resulted in
a reduction of rhodamine phalloidin-labeled F-actin rel-
ative to the normal glucose control (Fig. 10A). This pat-
tern of F-actin reduction as measured by a decrease in
the ratio of F-actin/g-actin fluorescence (Table 1) identi-
fies F-actin disassembly. Pretreatment with ZI prevented
F-actin disassembly in high glucose (Fig. 10B) and in-
creased the ratio of F-actin/g-actin fluorescence (Table 1)
suggesting enhanced assembly. To determine the role of
ROS in F-actin disassembly in high glucose, cells were
pretreated with Tempol, which prevented F-actin disas-
sembly in high glucose (Fig. 10C) and increased the ratio
of F-actin/g-actin fluorescence (Table 1). The absence of
osmotic effects on F-actin disassembly was observed by
comparing the effects of high D- and L-glucose (Fig. 10D).
DISCUSSION
In this study, we identified a pivotal role for mesangial
cell PKC-f in NADPH oxidase–dependent ROS induced
in high glucose. In addition, we demonstrated that in high
glucose, sustained PKC-f activity is dependent upon ROS
generation, thus suggesting a positive feedback. We iden-
tified that PKC-f–dependent mesangial cell F-actin disas-
sembly in high glucose requires ROS generation, and also
that PDGF stimulates ROS generation from NADPH
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Fig. 9. Role of phosphoinositide 3 kinase
(PI3 kinase) in reactive oxygen species (ROS)
production. Representative confocal images
of dichlorofluorescein (DCF)-loaded mesan-
gial cells cells growth-arrested in 5.6 mmol/L
normal glucose (NG) or 30 mmol/L D-glucose
[high glucose (HG)] for 48 hours. Cells were
stimulated with 50 ng/mL platelet-derived
growth factor (PDGF) for 10 minutes and/or
treated with 1 lmol/L Wortmannin (W) for
1 hour to inhibit PI3 kinase. Fluorescence
pixel intensity per cell was analyzed from
60 cells obtained from three separate experi-
ments (magnification bar 25 lm). ∗P < 0.001
vs. normal glucose control; ∗∗P < 0.001 vs. nor-
mal glucose + Wortmannin.
oxidase in mesangial cells through a PKC-f mechanism
that is not amplified in high glucose. Furthermore, we
showed that Akt phosphorylation is not enhanced in high
glucose or following exposure to ROS. While Akt phos-
phorylation is stimulated by PDGF in normal glucose, it
is not augmented in high glucose. Our data indicate that
PI3 kinase is not required by mesangial cells for ROS
generation in high glucose or in response to PDGF (see
Fig. 11).
ROS are pathogenic in the progression of diabetes
complications. ROS are postulated to exert their ef-
fects directly through oxidative stress [39] and indirectly
through second messenger signaling in a wide range of
pathways known to be involved in diabetes complica-
tions, including the PKC pathway [40]. The two primary
sources of ROS in nonphagocytic cells are mitochondria
[41] and NADPH oxidase [42]. In this present study, we
have shown that in high glucose, ROS are generated in
mesangial cells as early as 3 hours and that this pro-
duction is sustained up to 48 hours. The involvement
of high glucose-induced activation of PKC in NADPH
oxidase–dependent ROS production has been identified
recently [13]. Kitada et al [12] have shown that PKC-f is
required for NADPH oxidase activation and subsequent
oxidative stress in diabetic glomeruli. In our study, inhibi-
tion of PKC-f activity using an inhibitor of atypical PKC
isozymes prevented high glucose–induced ROS produc-
tion, thus demonstrating that PKC-f , the predominant
PKC isozyme expressed in mesangial cells, is involved in
mediating ROS generation. Dang et al [43] have shown
in human polymorphonuclear leukocytes that phospho-
rylation of p47phox by PKC-f is necessary for NADPH
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Fig. 10. Role of protein kinase C-f (PKC-f) and nicotinamide adenine dinucleotide phosphate (NADPH) oxidase in high glucose (HG)–mediated
F-actin disassembly. Dual-channel confocal fluorescence microscopy of rhodamine phalloidin-labeled F-actin and fluorescein isothiocyanate (FITC)-
DNase-1–labeled g-actin. (A) Cells were growth-arrested in 5.6 mmol/L normal glucose (NG) or 30 mmol/L D-glucose (HG) for 48 hours. (B)
Pretreatment with PKC-f peptide inhibitor (ZI) was used to determine the role of PKC-f . (C) Cells were pretreated with 100 nmol/L Tempol for
48 hours to assess the role of reactive oxygen species (ROS). (D) Osmotic effects on F-actin disassembly of 24.4 mmol/L L-glucose + 5.4 mmol/L
D-glucose was compared to 30 mmol/L D-glucose. Images are representative of three separate experiments (magnification bar 25 lm).
oxidase activation and superoxide anion production. In
our study, pretreatment of mesangial cells with the an-
tioxidant Tempol prevented both ROS accumulation and
enhanced PKC-f activity in high glucose. ROS may act to
sustain PKC-f activity by directly oxidizing the cysteine-
rich N-terminal regulatory domain of PKC-f [44].
Many studies have shown that antioxidant therapy [45–
48] or enhancement of antioxidant function using trans-
genic models [49, 50] prevent early progressive glomeru-
lopathy in the STZ-induced diabetic rodent models. In
our study, we explored the use of Tempol, a superox-
ide dismutase mimetic that effectively prevented ROS
accumulation in high glucose–exposed mesangial cells.
Oxidative stress and dysregulation of superoxide dismu-
tase and NADPH oxidase in renal insufficiency are re-
ported by Vaziri et al [51]. Tempol ameliorates oxidant
stress-mediated renal dysfunction in a rat model of in-
jury [52]. Taken together, oxidative stress appears to be
a common pathogenic mechanism and major contributor
to cellular dysfunction in diabetic ischemic and remnant
kidney disease.
PDGF is a mitogen that increases extracellular matrix
accumulation and growth of mesangial cells [17] and thus
contributes to the development of the diabetic mesan-
gial cell phenotype [53]. In human lens epithelial cells,
stimulation with PDGF induces the production of ROS
[54]. In smooth muscle cells, PDGF stimulates NADPH
oxidase–dependent ROS production through a pathway
that involves the coupling of the Ga i 1,2 subunit of the
trimeric G proteins to the PDGF tyrosine kinase receptor
[55]. In this study, we demonstrate that in normal glu-
cose, PDGF stimulates PKC-f activity and the genera-
tion of ROS in mesangial cells. Transfection of antisense
oligonucleotides against the NADPH oxidase subunit
p22phox as well as inhibition of PKC-f appear to pre-
vent PDGF-stimulated generation of ROS, thus further
Kwan et al: Activation of mesangial cell protein kinase C-f in high glucose 2539
Table 1. High glucose–induced F-actin disassembly
Control PKC-f inhibition Tempol
Normal glucose High glucose Normal glucose High glucose Normal glucose High glucose
F-actin 101.4 ± 3.2 39.3 ± 1.8 124.1 ± 3.6 94.2 ± 2.7 129.0 ± 3.3 118.5 ± 4.5
g-actin 53.8 ± 1.7 55.2 ± 1.7 53.7 ± 2.4 43.9 ± 1.0 42.1 ± 2.0 36.6 ± 1.4
F-actin/g-actin 1.92 ± 0.06 0.71 ± 0.03a 2.49 ± 0.10b 2.22 ± 0.10 3.47 ± 0.18a 3.68 ± 0.24
Dual-channel fluorescence confocal microscopy imaging analysis of rhodamine phalloidin-labeled F-actin and fluorescein isothiocyanate (FITC)-DNase-1–labeled
g-actin.
aP < 0.001 vs. normal glucose control.
bP < 0.05 vs. normal glucose control.
supporting the relationship between PKC-f and ROS
production.
Activation of PKC-f requires the initial phosphoryla-
tion of the Thr410 residue of the PKC-f activation loop
by PDK-1 [23]. PDK-1 can be activated by the PI3 kinase
product, phosphatidylinositol-3,4,5-trisphosphate. It has
been shown that PI3 kinase can activate PKC-f via PDK-
1 [24]. In our study, we found that high glucose does not in-
crease Akt phosphorylation. Hence, the increased PKC-f
activity and ROS production observed in mesangial cells
in high glucose appears to be independent of the PI3 ki-
nase pathway. In this study, we have shown that in normal
glucose, PDGF stimulates mesangial cell PI3 kinase ac-
tivity, PKC-f activity, and acute generation of ROS, none
of which are altered in high glucose. Bae et al [56] re-
port that PDGF-induced ROS generation requires the
activation of PI3 kinase in HepG2 cells. Sheu et al [57]
have shown that in nonserum-starved primary cultured
rat mesangial cells, PI3 kinase is activated in high glucose.
Our study was conducted in growth-arrested cells mim-
icking in vivo conditions, which may explain the lack of
PI3 kinase activation in high glucose in our experiments.
F-actin assembly plays a significant role in the main-
tenance of mesangial cell contractility, which is neces-
sary for control of the glomerular filtration surface area
[58]. Exposure to high glucose leads to partial F-actin
disassembly [9] which is mediated by both diacylglycerol-
sensitive PKCs [10] and PKC-f [11]. PKC-f regulates F-
actin disassembly in other cell types, including NIH3T3
mouse fibroblast cells [59]. The role played by NADPH
oxidase–dependent ROS generation in mesangial cell
actin cytoskeletal rearrangement is not well known. In
mesangial cells, inhibition of ROS production results in
the attenuation of high glucose–dependent gene expres-
sion of actin cytoskeleton regulatory proteins [60]. In this
current study, we show that pretreatment with Tempol in-
hibits F-actin disassembly in high glucose, thus suggesting
an integral role for ROS in the mediation of F-actin dis-
assembly. We also observe that Tempol pretreatment and
PKC-f inhibition result in increased actin polymerization
in normal glucose, as characterized by elevated F-actin/g-
actin ratios. It may be that in ambient glucose conditions,
ROS generation and PKC-f activity are required to en-
sure a basal degree of actin polymerization. By inhibiting
PKC-ζ
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NADPH
oxidase
PDGF
PDGF
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F-actin
disassembly
Akt
Pl3-kinaseNo effect on
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Fig. 11. Proposed positive feedback loop between nicotinamide ade-
nine dinucleotide phosphate (NADPH) oxidase–generated reactive
oxygen species (ROS) and protein kinase C-f (PKC-f) activation in
high glucose (HG). PKC-f–dependent F-actin disassembly in high glu-
cose requires ROS. Platelet-derived growth factor (PDGF) stimulates
NADPH oxidase production of ROS through a PKC-f–dependent
mechanism that is independent of phosphoinositide 3 kinase (PI3 ki-
nase) and remains unchanged in high glucose.
PKC-f activity and ROS production in normal glucose, it
is possible that the regulatory roles played by PKC-f and
ROS also become inhibited, thus resulting in enhanced
actin polymerization.
CONCLUSION
We have identified that in high glucose, mesangial cells
demonstrate a dependency of NADPH oxidase ROS gen-
eration on PKC-f , and that a positive feedback loop
exists between ROS and the activation of PKC-f . PKC-
f -dependent F-actin disassembly in high glucose also
requires ROS generation. We show that the degree of
activation of PKC-f and ROS production in high glu-
cose are similar to that observed in normal glucose during
acute stimulation with the potent growth factor PDGF.
PI3 kinase is neither activated in high glucose nor in-
volved in ROS generation during PDGF stimulation. The
interdependence of ROS generation and PKC-f activa-
tion appears central to the early response of mesangial
cells to high glucose.
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